« Previous
Next »
The Journal of Urology
Volume 182, Issue 5
, Pages 2099-2100
, November 2009
Prostanoid Receptor Subtypes: New Targets for OAB Drugs?
References
- Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, et al. editor. Incontinence, 4th International Consultation on Incontinence. Plymouth: Plymbridge Distributors Ltd, UK; 2009;p. 631–699
- . Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84:935
- Evaluation of flurbiprofen in detrusor instability. Br Med J. 1980;280:281
- . A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol. 1980;123:399
- . Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol. 2009;Epub ahead of print
- Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice. Am J Physiol Renal Physiol. 2008;295:F507
- The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007;99:442
- . Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol. 2004;172:1166
- Urothelium EP1 receptor facilitates the micturition reflex in mice. Biomed Res. 2008;29:105
- Evidence for prostaglandin involvement in neuro-modulation in the guinea pig bladder. Neurourol Urodyn. 2009;abstract 191
- Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat. Br J Pharmacol. 2009;Epub ahead of print
PII: S0022-5347(09)02160-0
doi: 10.1016/j.juro.2009.08.100
« Previous
Next »
The Journal of Urology
Volume 182, Issue 5
, Pages 2099-2100
, November 2009

